Phage International

Phage International is a biotechnology company specializing in the development and clinical application of bacteriophage therapy to combat antibiotic-resistant bacterial infections. The company operates the Phage Therapy Center in Tbilisi, Georgia, providing a specialized clinical environment for patients with chronic conditions that have failed standard antibiotic treatments. Their therapeutic process includes precise bacterial identification followed by the administration of specific phage cocktails tailored to the patient's infection. Phage International targets a wide range of pathogens, including MRSA, Pseudomonas, and E. coli, across various therapeutic areas such as urology and pulmonology. By bridging the gap between traditional Eastern European phage science and global patients, the company remains a key player in the field of personalized microbial therapy.